Evidence map›Paper›PMID 36241085›Full record

ReviewNeuropharmacology2022

Usage of L-type calcium channel blockers to suppress drug reward and memory driving addiction: Past, present, and future.

Hitoshi Morikawa, Cara C Young, Jasper A Smits

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Hitoshi MorikawaDepartment of Neuroscience and Waggoner Center for Alcohol and Addiction Research, USA. Electronic address: morikawa@utexas.edu.
Cara C YoungSchool of Nursing, USA.
Jasper A SmitsDepartment of Psychology, University of Texas at Austin, Austin, TX, USA.
Institute of Alcohol Studies · GBThe University of Texas at Austin · US

Funding

Experience-Dependent Regulation of Reward Learning and Addiction VulnerabilityR01DA054274 · NIDA · UNIVERSITY OF TEXAS AT AUSTIN · PI HITOSHI MORIKAWA · 2022 to 2026
$1.8M
Isradipine and Virtual Reality Cue Exposure for Smoking CessationR21DA049539 · NIDA · UNIVERSITY OF TEXAS AT AUSTIN · PI SMITS, JASPER, YOUNG, CARA CALLOWAY · 2019 to 2020
$430k
NIDA NIH HHS R01 DA054274NIDA NIH HHS R21 DA049539
6 · The paper itself

Abstract

Over the past three decades, L-type Ca

Indexed as

Behavior, AddictiveSubstance-Related DisordersAnimalsCalcium Channel BlockersCalcium Channels, L-TypeDopamineHumansRewardCalcium Channel BlockersCalcium Channels, L-TypeDopamineAddictionCue exposure therapyDopaminergic systemIsradipineL-type calcium channels

Identifiers

PMID36241085
PMCPMC10476140
OpenAlexW4304811041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.